Coccidioides Antigen Testing is Key to Faster & More Accurate Coccidioidomycosis Diagnosis
Adding coccidioides antigen testing to standard antibody and pathology testing for coccidioidomycosis is more effective than other diagnostic methods alone. Coccidioides antigen testing offers faster detection and earlier diagnosis. It also offers higher sensitivity in cases of severe disease and immunocompromised patients. Additionally, coccidioides antigen testing offers higher specificity, even in endemic areas.
Learn about the MiraVista Diagnostics MVista® Coccidioides Quantitative Ag EIA and the benefits of incorporating coccidioides antigen testing into your diagnostic protocol for coccidioidomycosis.
Coccidioides Antigen Testing Complements Antibody and Pathology in Immunocompromised Patients
Advantages of Coccidioides Antigen Testing
Antibody testing alone is not enough to quickly and accurately diagnose coccidioidomycosis in immunocompromised patients or meningitis. Missed or late diagnosis can be fatal. Early and accurate detection can improve patient outcomes and save lives.
- 93% in CSF meningitis cases
- 81% in immunocompromised patients
- 70% in moderate – severe cases
- 67% in mild cases when testing serum and urine
- 98% in non-fungal cases
- 90% in histoplasmosis
- in immunocompromised patients
- in endemic areas
- in meningitis
- same day test results for urine/BAL
- 1 day test results for serum/plasma/CSF
Coccidioides CSF Antigen Testing Improves Cocci Meningitis Diagnosis
Coccidioides Urine and Serum Antigen Testing Offer High Sensitivity to Coccidioidomycosis
Download MiraVista Diagnostics’ briefing on the Benefits of Coccidioides Antigen Testing in Coccidioidomycosis Diagnosis